This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons it is home to solid dividend stocks, including Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY) , two of the leading pharmaceutical companies in the world. In addition to their strong income profiles, both drugmakers look incredibly cheap at their current levels, making them excellent picks.
Nvidia (NASDAQ: NVDA) has dominated the artificial intelligence (AI) computing hardware game for the entirety of the AI arms race, but there's one company aiming to change that: Broadcom (NASDAQ: AVGO). While Nvidia's graphics processing units (GPUs) are best-in-class, Broadcom is looking to challenge Nvidia with something different: custom AI accelerators, which it calls XPUs.
ResultsCX, a Fort Lauderdale, FL-based provider of customer experience management (CXM) services, acquired Aucera (fka DialAmerica), a Mahwah, NJ-based provider of a customer experience management provider. The amount of the deal was not disclosed. Led by Christopher Conway, CEO, Aucera is a contact center delivering more than 100 million experiences a year across both nearshore and […] The post ResultsCX Buys Aucera appeared first on FinSMEs.
The price of many artificial intelligence (AI) stocks has dropped since the beginning of the year, creating a buying opportunity for investors looking to benefit from one of the largest tech trends in years. There's no guarantee of specific returns, but buying shares of AI leaders could produce significant gains as the technology balloons into a $15.7 trillion market by 2030.
Good Good Golf, a Prosper, TX-based golf, media, and lifestyle brand, raised $45M in funding. The round was led by Creator Sports Capital, with participation from Manhattan West Private Equity, Sunflower Bank, and Peyton Mannings Omaha Productions. The company intends to use the funds to accelerate its global expansion across content, retail, and live experiences, […] The post Good Good Golf Raises $45M in Funding appeared first on FinSMEs.
In this podcast, Motley Fool analyst David Meier and host Dylan Lewis discuss: February retail numbers showing continued consumer struggles, and why this upcoming retail earnings season will be a key read on the economy. Pepsi 's planned $2 billion acquisition of the Poppi soda brand, whose drinks include apple cider vinegar and prebiotics (fibers that feed gut bacteria).
Alvotech (NASDAQ: ALVO), a Reykjavik, Iceland-based biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, acquired Xbranes R&D operations and the biosimilar candidate XB003. The purchase price for the acquisition was approximately SEK 275M (approximately USD 27M) and will be payable as SEK 102.2M in cash at closing and by […] The post Alvotech Acquires Xbranes R&D Operations in Sweden appeared first on FinSMEs.
Alvotech (NASDAQ: ALVO), a Reykjavik, Iceland-based biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, acquired Xbranes R&D operations and the biosimilar candidate XB003. The purchase price for the acquisition was approximately SEK 275M (approximately USD 27M) and will be payable as SEK 102.2M in cash at closing and by […] The post Alvotech Acquires Xbranes R&D Operations in Sweden appeared first on FinSMEs.
Following Palantir Technologies ' (NASDAQ: PLTR) recent customer event, Jefferies analyst Brent Hill maintained an underperform (sell) rating on the shares with a $60 price target , implying potential downside of 29% from the current share price. Palantir stock has had an incredible run over the past two years, climbing 971%. The company's artificial intelligence (AI) platform has been in strong demand, but more analysts on Wall Street are starting to sound the alarm on the stock's high valuatio
AI company Fractal made a $20M investment in one of its product companies, Asper.ai, a NYC-based provider of an AI for growth platform for consumer goods and manufacturing. The company intends to use the funds to expand its impact, and enhance value for its customer base. Led by CEO Mohit Agarwal, Asper.ai enables interconnected and […] The post Asper.ai Receives $20M Investment from Fractal appeared first on FinSMEs.
If you're behind in your saving and investing for retirement, you're not alone. According to the 2024 Retirement Confidence Survey, fully 47% of workers have less than $100,000 socked away, and 29% have less than $25,000. Yikes! Even if you have, say, $500,000 saved, that might be far from enough. After all, if you apply the 4% rule and take out 4% of that in your first year of retirement, adjusting future years' withdrawals for inflation, you'll only get $20,000 in your first year.
Frazier Healthcare Partners, a Seattle-based, healthcare-focused private capital firm, received a passive, minority investment from Petershill at Goldman Sachs Alternatives. The amount of the deal was not disclosed. This passive minority investment will support the continued growth of the Frazier investment platform, enable increased investment by the general partner in existing and new funds and […] The post Frazier Healthcare Partners Receives Strategic Minority Investment from Petershil
These three stocks aren't conventionally seen as artificial intelligence (AI) stocks, yet AI is a critical part of the growth story of HVAC and building controls/software company Johnson Controls (NYSE: JCI) , and electrical solutions company nVent Electric (NYSE: NVT). Meanwhile, integrating AI-enabled solutions is the key to long-term growth at GE HealthCare (NASDAQ: GEHC).
Archer Review, a McKinney, TX-based health care education company and a portfolio company of Leeds Equity Partners, acquired OnlineMedEd, an Austin, TX-based provider of medical education curriculum and supplemental education solutions designed to support students and medical schools alike. The amount of the deal was not disclosed. With this acquisition, Archer Review will accelerate its […] The post Archer Review Acquires OnlineMedEd appeared first on FinSMEs.
Mediterranean fast-casual restaurant chain Cava Group (NYSE: CAVA) is a rapidly growing business. It's often compared to Chipotle Mexican Grill , with investors seeing it as the next big growth stock in the restaurant industry. Last year was a stellar one for Cava as its shares skyrocketed 162%. This year, however, has been a far different story. The restaurant's stock has slumped 30% and is now down more than 50% from its 52-week high of $172.43.
Olio Labs, a San Francisco, CA-based provider of a therapeutic design platform, raised $4.5M in funding. The round was led by Boom Capital and Overwater Ventures, with participation from Pioneer Fund, SciFounders, Scrum Ventures, Y Combinator (S23), and ZAKA. The company intends to use the funds to expand operations and its development efforts. Led by CEO David Tingley, Olio Labs has developed […] The post Olio Labs Raises $4.5M in Funding appeared first on FinSMEs.
It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020. Despite its generating record sales and profits through 2022, early projections of sustained demand for coronavirus vaccinations failed to materialize, leading to a sharp drop in the business.
Private equity firm Cinven is set to exit its majority stake in Viridium Group following a 3.5bn ($3.82bn) deal led by a consortium that includes Allianz, BlackRock, and Japans T&D Holdings, the companies announced on Wednesday, according to a report by Reuters. The deal marks a significant private equity exit for Cinven, which has been working on the sale for months.
Artificial intelligence (AI) is a huge opportunity for a device maker like Apple (NASDAQ: AAPL) to take advantage of. With more than 2.2 billion active Apple devices in the world, if the company can use AI to help create a new income stream for its operations, that can be a huge growth catalyst for the business, which is something Apple needs given its underwhelming growth in recent years.
In Alternative Views, Private Equity Wire goes behind closed doors with those in the know to get the latest on private markets.In our first instalment, we sat down with Patrick Marshall, Head of Private Credit and Chair of the Private Debt Investment Committee at Federated Hermes. Marshall shared his view on the evolving relationship between banks and private credit (00:12), high-level trends (1:42), his 2025 outlook (3:00), and the firms approach to risk (4.41).
They say a rising tide lifts all boats. Well, the reverse is true, too: A falling tide lowers all boats. As it is in the water, so it is in the stock market. Case in point: As of this writing, the tech-heavy Nasdaq Composite (NASDAQINDEX: ^IXIC) has fallen by more than 9% year to date. As the index has fallen, so have many prominent tech stocks. Apple is down 15%, Alphabet has lost 15%, and Nvidia has given up 12% of its value so far this year.
Coffee giant Starbucks (NASDAQ: SBUX) could use some Wall Street caffeine these days. As of this writing on March 18, the stock is down 15% since the end of February. The broader market is also swooning with a 5.6% S&P 500 (SNPINDEX: ^GSPC) decline in the same period, but Starbucks is taking a deeper dive. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.
By Bryce Sanders While youre attending the MDRT Annual Meeting or other conferences, your clients might think you are away on a paid holiday or they could see it as a benefit. It depends on how you position it.
Billionaire Stan Druckenmiller -- of Soros Fund and Duquesne fame -- was one of the first investors to catch on to Nvidia (NASDAQ: NVDA) as an artificial intelligence (AI) investment. He bought Nvidia stock in the fourth quarter of 2022, when it was around $15 a share. Since then, it has gone up hundreds of percentage points, completed a 10-for-1 stock split in 2024, and now trades at around $115.
We also answered questions about when to change your asset allocation during a correction, why Wall Street is so bad at price targets, the economic impact of tariffs and taking out a 401k loan to fund a down payment. Further Reading: 10 Great Lines From Where Are the Customers’ Yachts? The post What is the Point of Money? appeared first on A Wealth of Common Sense.
PDD Holdings (NASDAQ:PDD) , a notable operator in global e-commerce, unveiled its financial results for the fourth quarter of 2024 on March 20. The company reported non-GAAP earnings per share (EPS) of $2.76, slightly exceeding the analyst estimate of $2.74. However, revenue of $15.15 billion missed the consensus estimate by 2.5% amid competitive market pressures.
Shares of sports data and technology provider Sportradar (NASDAQ: SRAD) were up 10% this week as of 2:15 p.m. ET on Thursday, according to data provided by S&P Global Market Intelligence. Sportradar reported fourth-quarter earnings on Wednesday, wherein revenue and cash from operations grew by 26% and 36% in 2024. Where to invest $1,000 right now?
Sports apparel giant Nike (NYSE:NKE) reported fiscal 2025 third-quarter results on Thursday, March 20, that topped analysts' consensus estimates. Earnings per share (EPS) of $0.54 exceeded expectations of $0.30. Revenue beat projections at $11.27 billion but fell 9% year over year. Overall, the quarter reflected mixed results, with significant earnings driven by operational efficiencies overshadowing lingering revenue hurdles and gross margin pressures.
On Thursday, plenty of investors bellied up to the bar to put money into Boston Beer (NYSE: SAM) stock. Best known as the brewer of the Samuel Adams line of suds, the company received a recommendation upgrade from a top U.S. bank tracking its fortunes. In mid-afternoon trading, Boston Beer's share price was up by more than 3%. Fizzy potential Well before the market open that morning, Citigroup 's Filippo Falorni pushed his Boston Beer recommendation up one peg, to buy from the previous neutral.
The allure of online gambling has seen this market grow substantially in the last decade. In 2023 alone, the global gambling market generated around $540bn in revenue and its safe to say that the online segment played a major role. It has become a significant economic force in some countries, influencing the job market, government […] The post How Does iGaming Impact the Economy appeared first on FinSMEs.
Shares of major Chinese tech and consumer stocks such as tech conglomerates Alibaba (NYSE: BABA) and Tencent (OTC: TCEHY) , as well as digital online broker Futu Holdings (NASDAQ: FUTU) were all falling today. They were down 4.3%, 5.6%, and 5.2%, respectively, as of 1:49 PM ET. The across-the-board move indicates that the declines had to do with Chinese stocks broadly and not individual stock news.
Full-service dining restaurant chain specialist Darden Restaurants (NYSE:DRI) reported mixed fiscal 2025 third-quarter earnings on Thursday, March 20. Revenue of $3.16 billion rose 6.2% year over year but fell short of analysts' consensus expectations of $3.21 billion. Adjusted EPS of $2.80 was up by 6.9% year over year and matched expectations. The overall performance was solid, with some of the revenue gains coming from the October 2024 completion of its acquisition of Chuy's Tex-Mex restauran
Limassol, Cyprus, 20th March 2025, FinanceWire The post FXSpire Introduces False-Breakout Detection for Smarter EUR/USD Trading appeared first on FinSMEs.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
221 
Let's personalize your content